Tim Bertram
Director/Board Member bij NEXIMMUNE, INC.
Vermogen: 6 M $ op 29-02-2024
Profiel
Timothy A.
Bertram is a businessperson who founded ProKidney LLC and who has been at the helm of 5 different companies.
He is Chief Executive Officer for Twin City Bio LLC, Chief Executive Officer at InRegen and Chief Executive Officer of ProKidney LLC.
Dr. Bertram is also on the board of NexImmune, Inc.
In his past career he occupied the position of Chief Executive Officer at RegenMed Systems, Inc., Chief Executive Officer & Director at ProKidney Corp., Chief Scientific Officer of Tengion, Inc., Principal at Pfizer Inc., Principal at Procter & Gamble Co., Member of Journal Communications, Inc., Principal at Smithkline Beecham Pharmaceuticals (India) Ltd.
and Faculty Member at the University of Illinois.
Dr. Bertram received a doctorate from Iowa State University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
PROKIDNEY CORP.
2.08% | 22-05-2023 | 3 542 669 ( 2.08% ) | 6 M $ | 29-02-2024 |
NEXIMMUNE, INC.
0.26% | 31-10-2023 | 3 127 ( 0.26% ) | 20 951 $ | 29-02-2024 |
PROKIDNEY CORP. CLASS A
-.--% | 22-05-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Prokidney Equity LLC
inf% | 11-07-2022 | 4 944 938 ( inf% ) | - $ | Vandaag |
Actieve functies van Tim Bertram
Bedrijven | Functie | Begin |
---|---|---|
NEXIMMUNE, INC. | Director/Board Member | 01-01-2017 |
InRegen
InRegen Hospital/Nursing ManagementHealth Services InRegen develops cellular therapies for treating chronic kidney diseases. The firm's technology is able to identify the patient’s own healthy progenitor cells, and formulate them into a personalized product that can be re-injected into the damaged kidney for repair and regeneration. The company is headquartered in George Town, Cayman Islands. | Chief Executive Officer | 01-01-2016 |
ProKidney LLC
ProKidney LLC Packaged SoftwareTechnology Services ProKidney LLC develops therapies for kidney disease. The company was founded by Pablo Legorreta and is headquartered in Winston-Salem, NC. | Chief Executive Officer | 01-01-2019 |
Twin City Bio LLC | Chief Executive Officer | 01-01-2019 |
Eerdere bekende functies van Tim Bertram
Bedrijven | Functie | Einde |
---|---|---|
PROKIDNEY CORP. | Chief Executive Officer | 15-11-2023 |
TENGION, INC. | Chief Tech/Sci/R&D Officer | 31-12-2014 |
PFIZER, INC. | Corporate Officer/Principal | - |
Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - |
University of Illinois | Corporate Officer/Principal | - |
Opleiding van Tim Bertram
Iowa State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
PFIZER, INC. | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
TENGION, INC. | Health Technology |
NEXIMMUNE, INC. | Health Technology |
PROKIDNEY CORP. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Journal Communications, Inc.
Journal Communications, Inc. Publishing: NewspapersConsumer Services Journal Communications, Inc. is a media company with operations in television and radio broadcasting, publishing and digital media. The company operates through three segments: Publishing, Broadcasting and Corporate. The Broadcasting segment consists of 35 radio stations and 15 television stations in 12 states. The Publishing segment consists of a daily newspaper, the Milwaukee Journal Sentinel, which serves as the only major daily newspaper for the Milwaukee metropolitan area, and several community newspapers and shoppers in Wisconsin. The Corporate segment consists of unallocated corporate expenses and revenue eliminations. Journal Communications was founded in 1882 and is headquartered in Milwaukee, WI. | Consumer Services |
Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
RegenMed Systems, Inc. | |
InRegen
InRegen Hospital/Nursing ManagementHealth Services InRegen develops cellular therapies for treating chronic kidney diseases. The firm's technology is able to identify the patient’s own healthy progenitor cells, and formulate them into a personalized product that can be re-injected into the damaged kidney for repair and regeneration. The company is headquartered in George Town, Cayman Islands. | Health Services |
ProKidney LLC
ProKidney LLC Packaged SoftwareTechnology Services ProKidney LLC develops therapies for kidney disease. The company was founded by Pablo Legorreta and is headquartered in Winston-Salem, NC. | Technology Services |
Twin City Bio LLC |